Truepill

Healthcare platform for pharmacy and telehealth

Hayward, California, United States

About Truepill

Truepill provides a comprehensive healthcare platform that enhances access to medications, telehealth services, and diagnostic testing. The company operates accredited pharmacies that ship prescription and over-the-counter medications across the U.S., accommodating both insurance and cash payments. Truepill also offers telehealth solutions, allowing patients to consult with licensed physicians through various methods, including video and in-person visits, available 24/7 for multiple specialties. Additionally, Truepill provides diagnostic services with over 3,000 tests available through at-home kits and a network of labs. Unlike many competitors, Truepill integrates these services into a single platform, aiming to create a seamless healthcare experience. The company's goal is to make healthcare more accessible and affordable for patients and providers.

Hayward, CaliforniaHeadquarters
2016Year Founded
$248.4MTotal Funding
ACQUISITIONCompany Stage
Healthcare, Consumer GoodsIndustries
201-500Employees

Risks

Recent data breach raises concerns about Truepill's cybersecurity and patient data protection.
Multiple layoffs in 2022 may affect operational capabilities and employee morale.
Merger with LetsGetChecked could present integration challenges amid recent organizational changes.

Differentiation

Truepill offers a comprehensive healthcare platform integrating pharmacy, telehealth, and diagnostics.
They provide white-labeled services, allowing partners to brand their healthcare solutions.
Truepill's nationwide prescription fulfillment covers all 50 states, enhancing accessibility.

Upsides

Partnership with ScriptDrop enables same-day prescription delivery, meeting consumer demand for speed.
Increased telehealth demand post-COVID-19 boosts Truepill's service expansion opportunities.
Rising trend of at-home diagnostics aligns with Truepill's existing service offerings.

Funding

Total raised$248.43 M
Latest valuation$525.00 M
StageACQUISITION